These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8033084)

  • 41. Molecular analysis of occupational cancer: infrequent p53 and ras mutations in renal-cell cancer in workers exposed to gasoline.
    Roth S; Partanen T; Suitiala T; Anttila S; Ojajärvi A; Hemminki K; Vainio H; Husgafvel-Pursiainen K
    Int J Cancer; 1997 Nov; 73(4):492-6. PubMed ID: 9389561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
    Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
    Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frame-shift mutation and reduced transcript of p53 gene in a renal cell carcinoma cell line, RCC23.
    Horikawa I; Suzuki M; Yoshida MA; Oshimura M
    Hum Mol Genet; 1995 Apr; 4(4):771-3. PubMed ID: 7633433
    [No Abstract]   [Full Text] [Related]  

  • 44. A whole-genome analysis of allelic changes in renal cell carcinoma by in-gel competitive reassociation.
    Ohki R; Oishi M; Kiyama R
    Mol Carcinog; 1998 Jul; 22(3):158-66. PubMed ID: 9688141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P53 gene deficiency does not enhance instability of mouse minisatellites in somatic cells of normal tissues.
    Ohashi M; Hatakeyama K; Aizawa S; Kominami R
    Jpn J Cancer Res; 1996 Jul; 87(7):696-701. PubMed ID: 8698618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Instability of N-nitrosamides.
    Lijinsky W
    Science; 1974 Feb; 183(4123):368. PubMed ID: 17781919
    [No Abstract]   [Full Text] [Related]  

  • 47. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.
    Haque A; Brazeau D; Amin AR
    Eur J Cancer; 2021 May; 149():165-183. PubMed ID: 33865202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemopreventive potential of natural compounds in head and neck cancer.
    Rahman MA; Amin AR; Shin DM
    Nutr Cancer; 2010; 62(7):973-87. PubMed ID: 20924973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?
    Noon AP; Vlatković N; Polański R; Maguire M; Shawki H; Parsons K; Boyd MT
    Cancer; 2010 Feb; 116(4):780-90. PubMed ID: 20052733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
    Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
    Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.
    Bosnar MH; Pavelić K; Hrasćan R; Zeljko Z; Krhen I; Marekoyic Z; Krizanac S; Pavelíc J
    J Cancer Res Clin Oncol; 1997; 123(9):485-8. PubMed ID: 9341897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA mismatch repair gene mutations in human cancer.
    Peltomäki P
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):775-80. PubMed ID: 9255561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
    Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
    Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
    Akiyama T; Hamazaki S; Okada S
    Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proliferative heterogeneity of human renal cell carcinomas and prevalence of ras gene point mutations.
    Waldmann V; Rabes HM
    J Cancer Res Clin Oncol; 1996; 122(4):207-13. PubMed ID: 8601572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma.
    Rüschoff J; Bocker T; Schlegel J; Stumm G; Hofstaedter F
    Virchows Arch; 1995; 426(3):215-22. PubMed ID: 7773499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microsatellite instability in human prostate cancer.
    Watanabe M; Imai H; Shiraishi T; Shimazaki J; Kotake T; Yatani R
    Br J Cancer; 1995 Sep; 72(3):562-4. PubMed ID: 7669562
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microsatellite instability in ovarian neoplasms.
    King BL; Carcangiu ML; Carter D; Kiechle M; Pfisterer J; Pfleiderer A; Kacinski BM
    Br J Cancer; 1995 Aug; 72(2):376-82. PubMed ID: 7640221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microsatellite instability and other molecular abnormalities in human prostate cancer.
    Suzuki H; Komiya A; Aida S; Akimoto S; Shiraishi T; Yatani R; Igarashi T; Shimazaki J
    Jpn J Cancer Res; 1995 Oct; 86(10):956-61. PubMed ID: 7493915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.